These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25572590)

  • 21. Preliminary study on XAGE-1b gene and its mechanism for promoting tumor cell growth.
    Zhou B; Li T; Liu Y; Zhu N
    Biomed Rep; 2013 Jul; 1(4):567-572. PubMed ID: 24648988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NLS-dependent and insufficient nuclear localization of XAGE-1 splice variants.
    Zhao R; Tang B; Liu Y; Zhu N
    Oncol Rep; 2011 Apr; 25(4):1083-9. PubMed ID: 21305256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. XAGE-1 mRNA expression in prostate cancer and antibody response in patients.
    Koizumi F; Noguchi Y; Saika T; Nakagawa K; Sato S; Eldib AM; Nasu Y; Kumon H; Nakayama E
    Microbiol Immunol; 2005; 49(5):471-6. PubMed ID: 15905609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged survival of patients with lung adenocarcinoma expressing XAGE-1b and HLA class I antigens.
    Kikuchi E; Yamazaki K; Nakayama E; Sato S; Uenaka A; Yamada N; Oizumi S; Dosaka-Akita H; Nishimura M
    Cancer Immun; 2008 Aug; 8():13. PubMed ID: 18752338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
    Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
    Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
    Karr JF; Kantor JA; Hand PH; Eggensperger DL; Schlom J
    Cancer Res; 1995 Jun; 55(11):2455-62. PubMed ID: 7538903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C; Sanda MG
    Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice].
    Tan G; Wang ZY; Yin S
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):943-6. PubMed ID: 16759530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer.
    Chiriva-Internati M; Yu Y; Mirandola L; D'Cunha N; Hardwicke F; Cannon MJ; Cobos E; Kast WM
    Prostate; 2012 Jan; 72(1):12-23. PubMed ID: 21520158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
    Dannull J; Diener PA; Prikler L; Fürstenberger G; Cerny T; Schmid U; Ackermann DK; Groettrup M
    Cancer Res; 2000 Oct; 60(19):5522-8. PubMed ID: 11034097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association of XAGE-1 gene expression with clinical characteristics of lung cancer].
    Lai Q; Zhang L; Sun Y
    Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):786-9. PubMed ID: 20704819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
    Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
    Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Messenger RNA vaccine based on recombinant MS2 virus-like particles against prostate cancer.
    Li J; Sun Y; Jia T; Zhang R; Zhang K; Wang L
    Int J Cancer; 2014 Apr; 134(7):1683-94. PubMed ID: 24105486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Construction of eukaryotic expression vector of mouse alpha-fetoprotein cDNA and its expression in dendritic cells and in vitro antitumor effect on hepatoma].
    Zeng B; Lu FG; Liu XW; Yang DY; Fang WY; Wang J; Liao AJ; Shi W
    Ai Zheng; 2005 Nov; 24(11):1332-7. PubMed ID: 16552958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic immunotherapy strategies for cancer: mechanisms and clinical development.
    Aguilar LK; Guzik BW; Aguilar-Cordova E
    J Cell Biochem; 2011 Aug; 112(8):1969-77. PubMed ID: 21465529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells.
    Morgenroth A; Cartellieri M; Schmitz M; Günes S; Weigle B; Bachmann M; Abken H; Rieber EP; Temme A
    Prostate; 2007 Jul; 67(10):1121-31. PubMed ID: 17492652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cells.
    Hwang EC; Lim MS; Im CM; Kwon DD; Lee HJ; Nguyen-Pham TN; Lee YK; Lee JJ
    Scand J Immunol; 2013 Feb; 77(2):117-24. PubMed ID: 23126536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers.
    Zhang S; Zhang HS; Reuter VE; Slovin SF; Scher HI; Livingston PO
    Clin Cancer Res; 1998 Feb; 4(2):295-302. PubMed ID: 9516914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [State of the art about new therapeutic vaccines in prostate cancer: dendritic cells, engineered tumor cells and recombinant virus].
    Eymard JC; Gervais A; Jarcau R; Bernard J
    Bull Cancer; 2007 Jul; 94(7 Suppl):F69-76. PubMed ID: 17845996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells.
    Bühler P; Wolf P; Gierschner D; Schaber I; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Tacke M; Swamy M; Schamel WW; Elsässer-Beile U
    Cancer Immunol Immunother; 2008 Jan; 57(1):43-52. PubMed ID: 17579857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.